Keymed launches $400m Hong Kong IPO

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings
Asia

Keymed launches $400m Hong Kong IPO

Jonathan Breen
June 28, 2021 09:30 AM
Pharma_drugs_adobe_575x375.jpg

Chinese biotechnology company Keymed Biosciences has hit the market with an up to HK$3.1bn ($400.1m) IPO.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsEquityChinaChina International Capital CorpHong Kong SARAsiaGreater ChinaMorgan StanleyNortheast AsiaAsia PacificEmerging Markets
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article